Zura Bio (NASDAQ: ZURA) director plans 50,000-share sale after prior trades
Rhea-AI Filing Summary
Zura Bio Ltd (ZURA) received a notice under Rule 144 that director Someit Sidhu intends to sell common shares. The planned transaction involves 50,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate value of $287,712.50, currently associated with NASDAQ trading on 08/18/2026. The shares are tied to a stock option exercise for cash from the issuer on the same date. Over the prior three months, the same person reported additional sales of ZURA common stock.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 50,000 shares
Aggregate value of planned sale: $287,712.50
Planned sale date: 08/18/2026
+4 more
7 metrics
Planned shares to be sold
50,000 shares
Common stock intended for sale under Rule 144
Aggregate value of planned sale
$287,712.50
Total for 50,000 common shares listed with broker
Planned sale date
08/18/2026
Date associated with the 50,000-share transaction
Shares sold 08/17/2026
27,000 shares
Common shares sold by Someit Sidhu during past three months
Proceeds 08/17/2026
$151,343.10
Aggregate proceeds from 27,000-share sale
Shares sold 08/14/2026
40,000 shares
Common shares sold by Someit Sidhu during past three months
Shares sold 08/13/2026
51,000 shares
Common shares sold by Someit Sidhu during past three months
Key Terms
Rule 144, Stock Option Exercise, aggregate value
3 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Stock Option Exercise financial
"Common | 08/18/2026 | Stock Option Exercise | Issuer |"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
aggregate value financial
"Common ... | 50000 | 287712.50 |"
FAQ
What insider sale is disclosed for ZURA in this Form 144?
The notice reports that Someit Sidhu, a director of Zura Bio Ltd, intends to sell 50,000 common shares. The planned sale has an aggregate value of $287,712.50 and is associated with a stock option exercise dated 08/18/2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.